Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cephazolin prophylaxis for benign gynaecological laparoscopic surgery
ACTRN12617001528347Phase 4Completed
- Sponsor
- Royal Hospital for Women
- Start
- Feb 2019
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Cephazolin prophylaxis with Normal saline placebo (2 arms). Primary endpoints: Post-operative infection rates and Study feasibility. Started Feb 2019; status: completed.
02
Drugs
cefazolin
Beyond the preview
Go deeper on ACTRN12617001528347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001528347.